Nordic guidelines for neuraxial blocks in disturbed haemostasis from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

被引:96
作者
Breivik, H. [1 ]
Bang, U. [2 ]
Jalonen, J. [3 ]
Vigfusson, G. [4 ]
Alahuhta, S. [5 ]
Lagerkranser, M. [6 ]
机构
[1] Univ Oslo, Sect Anaesthesiol & Intens Care Med, Rikshosp, N-0027 Oslo, Norway
[2] Aarhus Univ Hosp, Dept Anaesthesia & Intens Care, Aarhus N, Denmark
[3] Univ Turku, Turku Univ Hosp, Dept Anaesthesiol & Intens Care, Turku, Finland
[4] Univ Hosp Landspitalinn, Dept Anaesthesiol & Intens Care, Reykjavik, Iceland
[5] Univ Oulu, Dept Anaesthesiol, Oulu, Finland
[6] Karolinska Inst, Dept Physiol & Pharmacol, Sect Anaesthesiol & Intens Care Med, Stockholm, Sweden
关键词
SPINAL-EPIDURAL HEMATOMA; MOLECULAR-WEIGHT HEPARIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INTRAVENOUS KETOROLAC TROMETHAMINE; SUBDURAL-HEMATOMA; PLATELET-FUNCTION; VENOUS THROMBOEMBOLISM; REGIONAL ANESTHESIA; LUMBAR PUNCTURE; PERIOPERATIVE MANAGEMENT;
D O I
10.1111/j.1399-6576.2009.02089.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background Central neuraxial blocks (CNBs) for surgery and analgesia are an important part of anaesthesia practice in the Nordic countries. More active thromboprophylaxis with potent antihaemostatic drugs has increased the risk of bleeding into the spinal canal. National guidelines for minimizing this risk in patients who benefit from such blocks vary in their recommendations for safe practice. Methods The Scandinavian Society of Anaesthesiology and Intensive Care Medicine (SSAI) appointed a task force of experts to establish a Nordic consensus on recommendations for best clinical practice in providing effective and safe CNBs in patients with an increased risk of bleeding. We performed a literature search and expert evaluation of evidence for (1) the possible benefits of CNBs on the outcome of anaesthesia and surgery, for (2) risks of spinal bleeding from hereditary and acquired bleeding disorders and antihaemostatic drugs used in surgical patients for thromboprophylaxis, for (3) risk evaluation in published case reports, and for (4) recommendations in published national guidelines. Proposals from the taskforce were available for feedback on the SSAI web-page during the summer of 2008. Results Neuraxial blocks can improve comfort and reduce morbidity (strong evidence) and mortality (moderate evidence) after surgical procedures. Haemostatic disorders, antihaemostatic drugs, anatomical abnormalities of the spine and spinal blood vessels, elderly patients, and renal and hepatic impairment are risk factors for spinal bleeding (strong evidence). Published national guidelines are mainly based on experts' opinions (weak evidence). The task force reached a consensus on Nordic guidelines, mainly based on our experts' opinions, but we acknowledge different practices in heparinization during vascular surgery and peri-operative administration of non-steroidal anti-inflammatory drugs during neuraxial blocks. Conclusions Experts from the five Nordic countries offer consensus recommendations for safe clinical practice of neuraxial blocks and how to minimize the risks of serious complications from spinal bleeding. A brief version of the recommendations is available on http://www.ssai.info.
引用
收藏
页码:16 / 41
页数:26
相关论文
共 147 条
[11]   Uneventful removal of an epidural catheter guided by impedance aggregometry in a patient with recent coronary stenting and treated with clopidogrel and acetylsalicylic acid [J].
Bergmann, Lars ;
Kienbaum, Peter ;
Grlinger, Klaus ;
Peters, Rirgen .
REGIONAL ANESTHESIA AND PAIN MEDICINE, 2007, 32 (04) :354-357
[12]   Platelet dysfunction in renal failure [J].
Boccardo, P ;
Remuzzi, R ;
Galbusera, M .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (05) :579-589
[13]   Delayed symptomatic presentation of epidural hematoma after epidural catheter anesthesia - Case report [J].
Boco, Tibor ;
Deutsch, Harel .
SPINE, 2007, 32 (22) :E649-E651
[14]   Renal effects of COX-2-selective inhibitors [J].
Brater, DC ;
Harris, C ;
Redfern, JS ;
Gertz, BJ .
AMERICAN JOURNAL OF NEPHROLOGY, 2001, 21 (01) :1-15
[15]  
BREIVIK H, 2008, CLIN PAIN MANAGEMENT, P311
[16]  
Breivik H., 2007, Pain, P255
[17]  
BROSSTAD F, 2005, ARTERIELL VENOS TROM
[18]   Central neuraxial block: defining risk more clearly [J].
Buggy, D. J. .
BRITISH JOURNAL OF ANAESTHESIA, 2009, 102 (02) :151-153
[19]   Low-dose aspirin for secondary cardiovascular prevention -: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation -: review and meta-analysis [J].
Burger, W ;
Chemnitius, JM ;
Kneissl, GD ;
Rücker, G .
JOURNAL OF INTERNAL MEDICINE, 2005, 257 (05) :399-414
[20]  
Campbell NRC, 1998, CLIN INVEST MED, V21, P71